Parmax Pharma Ltd
₹0.00▲ +0.00 (+0.00%)
540359·NSE·Healthcare
Market Cap
49.10 Cr
PE Ratio
—
Volume
—
Day High - Low
—
52W High-Low
131.15 - 22.60
₹0.00▲ +0.00 (+0.00%)
Market Cap49.10 Cr
PE Ratio—
Volume—
Day High - Low—
52W High-Low131.15 - 22.60
Parmax Pharma Ltd (540359): company summary
Parmax Pharma Ltd (540359) is a micro-cap Healthcare company valued at ₹49 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Parmax Pharma Ltd (540359) is a micro-cap Healthcare company valued at ₹49 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -7.7% a year over three years. Return on equity is 105.3%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -7.15 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
1.1/10
Poor
Fair Value
Sign in to see
ROE
105.30%
Strong
P/E
—
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Poor
Price performance
52W₹22.60
₹131.15
DocStoX take
Held back by growth (0.0). Scored on 3 of 5 measures.
DocStoX score
Low confidence1.1
/10
Poor
Quality
Weak
ROE 105.3%
Valuation
No data
No valuation multiples
Growth
Flat
Revenue -14.3% 5Y CAGR
Risk
Elevated
D/E 0.00
Momentum
No data
No technical indicators
Scored on 3 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹49 Cr
52W High / Low
₹131 / ₹23
Dividend Yield
0.00%
Promoter Holding
30.80%
EPS (TTM)
₹-5.59
Book Value
—
Key highlights
- Strong returns on equity (105%)
- Low leverage — D/E 0.00
- Revenue shrinking 14% a year
- Loss-making in some of the last 5 years
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Parmax Pharma Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Parmax Pharma Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value Parmax Pharma Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing